NM_152490.5:c.397G>A
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_152490.5(B3GALNT2):c.397G>A(p.Glu133Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000378 in 1,614,120 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_152490.5 missense
Scores
Clinical Significance
Conservation
Publications
- muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscle-eye-brain diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intellectual disabilityInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_152490.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| B3GALNT2 | NM_152490.5 | MANE Select | c.397G>A | p.Glu133Lys | missense | Exon 4 of 12 | NP_689703.1 | ||
| B3GALNT2 | NM_001277155.3 | c.520G>A | p.Glu174Lys | missense | Exon 5 of 8 | NP_001264084.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| B3GALNT2 | ENST00000366600.8 | TSL:1 MANE Select | c.397G>A | p.Glu133Lys | missense | Exon 4 of 12 | ENSP00000355559.3 | ||
| B3GALNT2 | ENST00000313984.3 | TSL:1 | c.520G>A | p.Glu174Lys | missense | Exon 5 of 8 | ENSP00000315678.3 | ||
| B3GALNT2 | ENST00000676288.1 | c.520G>A | p.Glu174Lys | missense | Exon 5 of 13 | ENSP00000502392.1 |
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152144Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000705 AC: 177AN: 251164 AF XY: 0.000987 show subpopulations
GnomAD4 exome AF: 0.000396 AC: 579AN: 1461858Hom.: 12 Cov.: 32 AF XY: 0.000565 AC XY: 411AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000204 AC: 31AN: 152262Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74456 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
B3GALNT2: BP4, BS2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11 Benign:1
B3GALNT2-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at